Premium
Adult domiciliary oxygen therapy: Position statement of the Thoracic Society of Australia and New Zealand
Author(s) -
Young Iven H,
Crockett Alan J,
McDonald Christine F,
Young Iven H,
Crockett Alan J,
McDonald Christine F
Publication year - 1998
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1998.tb123340.x
Subject(s) - oxygen therapy , position statement , life expectancy , medicine , supplemental oxygen , intensive care medicine , lung disease , quality of life (healthcare) , chronic disease , pulmonary disease , physical therapy , gerontology , lung , environmental health , nursing , family medicine , population
Evidence shows that patients with chronic obstructive pulmonary disease and a stable daytime Pao 2 of 55 mm Hg or less will have longer life expectancy if given supplemental oxygen to keep the Pao 2 above 60 mm Hg, preferably for longer than 15 hours a day, including sleep. There is some evidence for improved quality of life. It is reasonable to offer this therapy for other lung diseases which cause chronic hypoxaemia, and there are also less well defined indications for supplemental oxygen during exercise, sleep and air travel.